Could Postponement of Intercept’s Expected NASH Panel Impact Its PDUFA Date?

 
• By Joseph Haas
  
Building icon with inscription FDA and flag of The United States over abstract background. - Illustration
The status of imminent advisory committee reviews is in question with CDER's meeting cancellation notice
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip